More on CVS Caremark's Q4


CVS Caremark (CVS) saw broad sales growth in Q4, with Pharmacy Services revenue up 5.2% and Retail Pharmacy sales growth of 5.6%.

Retail Pharmacy Segment same store sales rose 4.0% during the period.

Gross profit rate fell 60 bps to 30.7%.

The company expects 2014 EPS of $4.36-$4.50 vs. $4.47 consensus.

A conference call is scheduled for 8:30 am where more details on the company's exit from tobacco could be discussed. (webcast)

CVS +0.7% premarket

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs